PH

Electronic Skin Patch Market worth $27.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, May 9, 2024

Connected electronic skin patches in Wireless Connectivity segment is expected to account for the largest share during the forecast period.

Key Points: 
  • Connected electronic skin patches in Wireless Connectivity segment is expected to account for the largest share during the forecast period.
  • Diabetes Management segment in Electronic Skin Patch Market will account for largest share during the forecast period.
  • Healthcare segment in Electronic Skin Patch Market will account for largest share during the forecast period.
  • Based on end user, the electronic skin patch market has been categorized into healthcare, fitness & sports, and other end users.

Electronic Skin Patch Market worth $27.0 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, May 9, 2024

Connected electronic skin patches in Wireless Connectivity segment is expected to account for the largest share during the forecast period.

Key Points: 
  • Connected electronic skin patches in Wireless Connectivity segment is expected to account for the largest share during the forecast period.
  • Diabetes Management segment in Electronic Skin Patch Market will account for largest share during the forecast period.
  • Healthcare segment in Electronic Skin Patch Market will account for largest share during the forecast period.
  • Based on end user, the electronic skin patch market has been categorized into healthcare, fitness & sports, and other end users.

Mercury Analyzer Market worth $426 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, May 8, 2024

Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.

Key Points: 
  • Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.
  • Additionally, strict regulations aimed at reducing mercury emissions from industrial sources are driving the demand for mercury analyzers in this sector.
  • The Asia Pacific region for mercury analyzer industry is expected to grow at the highest CAGR during the forecast period.
  • In addition, governments are enforcing stricter emission standards, pushing industries to adopt mercury analyzers for monitoring and controlling mercury emissions .

Mercury Analyzer Market worth $426 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, May 8, 2024

Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.

Key Points: 
  • Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.
  • Additionally, strict regulations aimed at reducing mercury emissions from industrial sources are driving the demand for mercury analyzers in this sector.
  • The Asia Pacific region for mercury analyzer industry is expected to grow at the highest CAGR during the forecast period.
  • In addition, governments are enforcing stricter emission standards, pushing industries to adopt mercury analyzers for monitoring and controlling mercury emissions .

Monteloeder's Award-Winning Lemon Verbena Enters into a Quest of Discovery at Hub De La Vera

Retrieved on: 
Tuesday, May 7, 2024

MADRID, May 7, 2024 /PRNewswire/ -- Nutraceuticals leader Monteloeder, S.L., a subsidiary of SUANNUTRA, is participating in La Vera Campo Arañuelo Hub, a visionary project that will bring cultivation and production of its flagship botanical lemon verbena (Aloysia citrodora) to Cáceres, Spain. There, it will serve as a keystone ingredient for research and agricultural innovation and will replace tobacco plants. Monteloeder will highlight lemon verbena as a core constituent of its bioactive ingredient portfolio at Vitafoods Europe in Geneva, 14-16 May.

Key Points: 
  • Monteloeder will highlight lemon verbena as a core constituent of its bioactive ingredient portfolio at Vitafoods Europe in Geneva, 14-16 May.
  • "Lemon verbena is naturally graced with a versatile spectrum of beneficial traits," explains Maria Ángeles Gutiérrez Marketing Director of SUANNUTRA.
  • Monteloeder is one of seven companies taking part in the La Vera Campo Arañuelo Hub agronomical research campaign.
  • The lemon verbena will grow alongside 14 other botanical crops, including sage, hops, and lemon balm.

International Battery Metals (IBAT) and US Magnesium Sign Agreement to Install World's First Modular Direct Lithium Extraction (DLE) Plant

Retrieved on: 
Monday, May 6, 2024

"Our commercial operations with US Mag will advance a productive lithium extraction operation," said Garry Flowers, IBAT CEO.

Key Points: 
  • "Our commercial operations with US Mag will advance a productive lithium extraction operation," said Garry Flowers, IBAT CEO.
  • IBAT's first-of-its-kind patented modular, mobile lithium extraction plant also has been independently verified to extract more than 97% of available lithium from brine.
  • "International Battery Metals' patented Modular Extraction Technology will be the basis of future lithium extraction from brine resources around the world.
  • The agreement provides IBAT with royalties from US Mag based on lithium sales, as well as payments for equipment operations based on lithium prices and performance.

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Retrieved on: 
Wednesday, April 24, 2024

BURLINGTON, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has enrolled the first participant in the pivotal pharmacokinetic (PK) study of SCP-111 (furosemide 80 mg/mL), an investigational, low volume, pH neutral formulation of furosemide administered via an auto-injector.

Key Points: 
  • The auto-injector is being developed as a complement to the FDA approved On-body Infusor in an effort to provide patients with a subcutaneous injection and prescribers with treatment flexibility.
  • If approved, the Company believes the auto-injector also has the potential to meaningfully reduce manufacturing costs.
  • FUROSCIX is not indicated for use in emergency situations or in patients with acute pulmonary edema.
  • The most common adverse reactions with FUROSCIX administration in clinical trials were site and skin reactions including erythema, bruising, edema, and injection site pain.

Inspiro Named Outsource Partner of the Year in 2024 Customer Service Excellence Awards

Retrieved on: 
Thursday, April 11, 2024

MANILA, Philippines, April 12, 2024 (GLOBE NEWSWIRE) -- Inspiro, a global leader in customer experience outsourcing, has been awarded the title of Outsourcing Partner of the Year at the prestigious 2024 Excellence in Customer Service Awards.

Key Points: 
  • MANILA, Philippines, April 12, 2024 (GLOBE NEWSWIRE) -- Inspiro, a global leader in customer experience outsourcing, has been awarded the title of Outsourcing Partner of the Year at the prestigious 2024 Excellence in Customer Service Awards.
  • Additionally, Chief Operations & Sales Officer Rommel Regino was recognized as Executive of the Year for his exceptional leadership in driving operational excellence and client satisfaction.
  • “In today’s dynamic environment, customer service teams and suppliers have had to adapt significantly,” said Maria Jimenez, Chief Nominations Officer at the Business Intelligence Group.
  • The Excellence in Customer Service Awards celebrate those who are winning by supporting their customers and those who are developing the tools to help others find success.

Global Yeast Strategic Industry Report 2024: Market to Reach $11.6 Billion by 2030 - Changing Consumer Preferences for Sophisticated Beverages and Surging Popularity of Probiotic Functional Foods - ResearchAndMarkets.com

Retrieved on: 
Friday, April 19, 2024

The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach a revised size of US$11.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030.

Key Points: 
  • The global market for Yeast estimated at US$6.2 Billion in the year 2023, is projected to reach a revised size of US$11.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030.
  • In this competitive scenario, the global market share percentages in 2023 and 2020 reflect the dynamics within the yeast market.
  • Despite pandemic challenges, the outlook for the yeast market remains positive, buoyed by major demand growth drivers like bread and other baked products.
  • The Yeast market in the U.S. is estimated at US$1.6 Billion in the year 2023.

Global Pulmonary Hypertension Community 'United for' World PH Day 2024

Retrieved on: 
Wednesday, April 24, 2024

WASHINGTON, April 24, 2024 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association will unite with over 80 organizations globally on Sunday, May 5, to recognize World Pulmonary Hypertension Day. World PH Day aims to raise awareness of pulmonary hypertension, a rare, complex, life-threatening disease that affects more than 75 million adults and children worldwide across all ethnic groups. There is currently no cure for PH, or high blood pressure in the lungs that causes symptoms such as shortness of breath, fatigue and chest pain.

Key Points: 
  • World pulmonary hypertension community to unite on May 5 to raise awareness, offer support and advocate for PH.
  • WASHINGTON, April 24, 2024 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association will unite with over 80 organizations globally on Sunday, May 5, to recognize World Pulmonary Hypertension Day.
  • World PH Day aims to raise awareness of pulmonary hypertension, a rare, complex, life-threatening disease that affects more than 75 million adults and children worldwide across all ethnic groups.
  • PHA encourages the global PH community to raise awareness about key issues facing those with PH using resources from its World PH Day webpage .